Put it this way, IMO most DM2 pts have weight problems and have higher trig levels, so most of them will be given or have the opportunity to be on V. Im sure Mr Cardio will agree.....
My 2cents. Somebody mentioned diabetic population in US is 30M. 10% penetration will be 3M, which translate to 4.5B annual rev per Dancing.
Put this in perspective with Statin add-on, which is primary target population for V and has 40M in US. But they are on only half time, so translate to 20M per HDG. So this diabetic SOC just snapped another equivalent market as stain add-on for V.